Literature DB >> 31352085

Factors Associated to Arterial Stiffness in Patients With Symptomatic Peripheral Artery Disease.

Antonio Henrique Germano-Soares1, Breno Quintella Farah2, Aluísio Andrade-Lima3, Wagner Ribeiro Domingues4, Bruno Remígio Cavalcante1, Marilia de Almeida Correia5, Nelson Wolosker6, Gabriel Grizzo Cucato6, Raphael Mendes Ritti-Dias7.   

Abstract

BACKGROUND: The aim of this study was to identify the clinical factors associated with arterial stiffness in patients with symptomatic peripheral artery disease.
METHODS: In this cross-sectional study, 181 patients (67% men; mean aged 66 ± 9 years) were recruited and had their central arterial stiffness assessed by carotid-femoral pulse wave velocity (cf-PWV). Clinical characteristics are sociodemographic data, body mass index, comorbid conditions, and walking capacity.
RESULTS: Multiple linear regression analysis showed that age (b = 0.182, P = 0.032), body mass index (b = 0.254, P = 0.002), and mean blood pressure (b = 0.249, P = 0.021) were positively associated with cf-PWV.
CONCLUSIONS: Our results showed that the aging, elevated body mass index, and higher blood pressure are clinical factors associated with increased arterial stiffness in patients with peripheral artery disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31352085     DOI: 10.1016/j.avsg.2019.04.036

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  1 in total

1.  Effect of Creatine Supplementation on Functional Capacity and Muscle Oxygen Saturation in Patients with Symptomatic Peripheral Arterial Disease: A Pilot Study of a Randomized, Double-Blind Placebo-Controlled Clinical Trial.

Authors:  Wagner Jorge Ribeiro Domingues; Raphael Mendes Ritti-Dias; Gabriel Grizzo Cucato; Nelson Wolosker; Antônio Eduardo Zerati; Pedro Puech-Leão; Daniel Boari Coelho; Pollyana Mayara Nunhes; André Alberto Moliterno; Ademar Avelar
Journal:  Nutrients       Date:  2021-01-05       Impact factor: 5.717

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.